Consequently, to further elucidate the role of ICBP90, we hypothesised that ICBP90 may be an intermediary actor in the E2F-induced TopoIIα expression, and that its expression may be deregulated in cancer cells vs noncancer cells. This evidence concerns the gene UHRF1 and cancer.